Abstract:The prevalence of diabetes has been accelerating at an alarming rate in the last decade; some describe it as an epidemic. Diabetic eye complications are the leading cause of blindness in adults aged 25-74 in the United States. Early diagnosis and development of effective preventatives and treatments of diabetic retinopathy are essential to save sight. We describe efforts to establish functional indicators of retinal health and predictors of diabetic retinopathy. These indicators and predictors will be needed as markers of the efficacy of new therapies. Clinical trials aimed at either prevention or early treatments will rely heavily on the discovery of sensitive methods to identify patients and retinal locations at risk, as well as to evaluate treatment effects. We report on recent success in revealing local functional changes of the retina with the multifocal electroretinogram (mfERG). This objective measure allows the simultaneous recording of responses from over 100 small retinal patches across the central 45 degrees field. We describe the sensitivity of mfERG implicit time measurement for revealing functional alterations of the retina in diabetes, the local correspondence between functional (mfERG) and structural (vascular) abnormalities in eyes with early nonproliferative retinopathy, and longitudinal studies to formulate models to predict the retinal sites of future retinopathic signs. A multivariate model including mfERG implicit time delays and 'person' risk factors achieved 86% sensitivity and 84% specificity for prediction of new retinopathy development over one year at specific locations in eyes with some retinopathy at baseline. A preliminary test of the model yielded very positive results. This model appears to be the first to predict, quantitatively, the retinal locations of new nonproliferative diabetic retinopathy development over a one-year period. In a separate study, the predictive power of a model was assessed over one- and two-year follow-ups. This permitted successful prediction of new retinopathy development in eyes with and without retinopathy at baseline. Finally, we briefly describe our current research efforts to (a) locally predict future sight-threatening diabetic macular edema, (b) investigate local retinal function change in adolescent patients with diabetes, and (c) better understand the physiological bases of the mfERG delays. The ability to predict the retinal locations of future retinopathy based on mfERG implicit time provides clinicians a powerful tool to screen, follow-up, and even consider early prophylactic treatment of the retinal tissue in diabetic patients. It also aids identification of 'at risk' populations for clinical trials of candidate therapies, which may greatly reduce their cost by decreasing the size of the needed sample and the duration of the trial.

Assessment of functional changes in long‐standing type 1 diabetic patients without diabetic retinopathy with multifocal electroretinogram

Changes in visual function in long‐term type 1 diabetic patients without diabetic retinopathy using full‐field electroretinogram

Retinal Function in Long-Term Type 1 Diabetes without Retinopathy: Insights from Pattern Electroretinogram and Pattern Visual Evoked Potentials Assessments

Electrophysiological findings in long-term type 1 diabetes patients without diabetic retinopathy using different ERG recording systems

Multifocal Electroretinogram Can Detect the Abnormal Retinal Change in Early Stage of type2 DM Patients without Apparent Diabetic Retinopathy

The characteristics of multifocal electroretinogram in diabetic patients without retinopathy

Retinal Function in Normal and Diabetic Eyes Mapped with the Slow Flash Multifocal Electroretinogram.

Characteristics of the Multifocal Electroretinogram in Type 2 Diabetes Without Clinically Apparent Retinopathy

Abnormalities of retinal function in type 2 diabetes mellitus patients without clinical diabetic retinopathy detected by multifocal electroretinogram

Tracking Macular Sensitivity and Inner Retinal Thickness in Long-Term Type 1 Diabetes: A Five-Year Prospective Examination in Patients without Diabetic Retinopathy

Changes in macular sensitivity in long‐term type 1 diabetic patients without diabetic retinopathy after 5 years of follow‐up

Multifocal Electroretinogram Delays Predict Sites of Subsequent Diabetic Retinopathy.

Comparison of Mferg Waveform Components and Implicit Time Measurement Techniques for Detecting Functional Change in Early Diabetic Eye Disease

Early functional and microcirculatory changes in patients with type 1 diabetes mellitus and no apparent diabetic retinopathy

Association Between Multifocal ERG Implicit Time Delays and Adaptation in Patients with Diabetes.

Multimodal Imaging Assessment of Vascular and Neurodegenerative Retinal Alterations in Type 1 Diabetic Patients without Fundoscopic Signs of Diabetic Retinopathy

Study of Electrophysiological in Diabetes Mellitus

Changes of the Mf-Erg First Order Kernel in Early Diabetic Retinopathy

A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Are We Overlooking the Neurodegeneration in the Early Stage of Type 1 Diabetes Mellitus without Visual Impairment or Diabetic Retinopathy: Is It Probably Occurred before Retinal Vasculature Dysfunction?

Multifocal electroretinogram in the diagnosis of Stargardt disease